The Ethical Frontier: Science vs. Morality
Esta actividad de comprensión auditiva se divide en tres partes para poner a prueba tu capacidad de entender detalles, completar información y captar ideas abstractas. Escucha atentamente el audio para responder a las preguntas de opción múltiple y de completar espacios según las instrucciones de cada sección.
🔊
Part 1 — Conversation (questions 1–6)
| # |
Question |
Options |
| 1 |
What is the primary concern raised by Speaker 1 regarding gene-editing? |
The high cost of the technology for average families. / The potential for a slippery slope towards eugenics. / The lack of interest from the scientific community. / The difficulty of predicting genetic outcomes. |
| 2 |
How does Speaker 2 justify the use of gene-editing technology? |
By claiming it is a way to improve human intelligence. / By arguing it is a moral obligation to prevent suffering. / By suggesting it will eventually be cheap and accessible. / By stating that scientific progress is unstoppable. |
| 3 |
What does Speaker 1 suggest about the relationship between law and innovation? |
Laws are often too strict and hinder scientific progress. / Regulations are usually ahead of the pace of technology. / The legal framework struggles to keep up with rapid innovation. / International laws are sufficient to control all risks. |
| 4 |
According to the speakers, what is a significant social risk of these technologies? |
A complete loss of privacy in the modern world. / The widening of social inequality between the wealthy and others. / The total disappearance of traditional family structures. / A lack of government funding for basic research. |
| 5 |
What is the 'classic tension' mentioned by Speaker 2? |
Between doctors and the pharmaceutical industry. / Between economic profit and scientific truth. / Between scientific progress and human values. / Between government control and individual freedom. |
| 6 |
What does the term 'biological divide' refer to in the context of the conversation? |
The difference between different species of organisms. / A gap in health and genetics between social classes. / The separation of humans from the natural environment. / The conflict between different types of biological research. |
Part 2 — Monologue: sentence completion (questions 7–12)
Complete each sentence with 1–3 words from the recording.
1. The speaker feels that the potential benefits of gene-editing are _.
2. The conversation touches on the risk of creating _.
3. Speaker 1 worries that we might trigger a _ of unforeseen biological issues.
4. The speaker notes that the regulatory framework is often _ rather than proactive.
5. The discussion highlights a potential _ to match the economic one.
6. The speaker describes the thought of a biological divide as _.
Part 3 — Panel discussion (questions 13–18)
13. What is the main theme of the narrator's monologue?
- The history of scientific discovery throughout the ages.
- The ethical challenges posed by expanding scientific capabilities.
- The technical requirements for modern medical diagnostics.
- The importance of funding scientific research globally.
14. Using AI in diagnostics raises questions primarily about:
- The cost of implementing new technology.
- The speed of medical results.
- The issue of accountability and liability.
- The accuracy of human clinicians.
15. What is 'dual-use' research as described by the narrator?
- Research that serves both humans and animals.
- Research that can be used for both good and harmful purposes.
- Research conducted by two different scientific institutions.
- Research that requires both funding and ethical oversight.
16. What does the 'precautionary principle' suggest?
- Innovation should always take priority over safety.
- Scientific consensus must be reached before any research begins.
- The burden of proof for safety lies with those proposing the action.
- All scientific research should be stopped until risks are zero.
17. According to the panel, why is complete neutrality in science considered a myth?
- Because scientists often manipulate their data.
- Because research is conducted by humans influenced by their culture.
- Because all science is funded by political parties.
- Because the scientific method is inherently flawed.
18. What does Speaker 1 suggest is a consequence of profit-driven research?
- It leads to faster breakthroughs in medicine.
- It results in the neglect of certain areas like rare diseases.
- It ensures that all research is high quality.
- It makes science more objective and less biased.
Vocabulario clave
- staggering — asombroso / impactante 🔊
- the crux of the matter — el quid de la cuestión / el punto crucial 🔊
- mitigate — mitigar / suavizar 🔊
- nuanced — matizado / con matices 🔊
- stifle — sofocar / frenar 🔊
- on the precipice — al borde de / en el precipicio 🔊
- inherently — intrínsecamente 🔊
- tethered to — vinculado a / atado a 🔊
Respuestas
Part 1: 1. A · 2. B · 3. A · 4. D · 5. B · 6. A
Part 2: 1. staggering · 2. designer babies · 3. cascade · 4. reactive · 5. biological divide · 6. a chilling thought
Part 3: 13. C · 14. A · 15. A · 16. B · 17. B · 18. C
Transcript
Ver transcript completo
SEGMENT 1 — CONVERSATION
Speaker 1: I was reading that article last night about the new gene-editing trials, and honestly, it left me feeling a bit unsettled. It’s one of those topics where the potential benefits are staggering, yet the moral implications are just... overwhelming.
Speaker 2: I know exactly what you mean. It’s that classic tension between scientific progress and the preservation of our fundamental human values. It’s not just about whether we *can* do something anymore, but whether we *should*.
Speaker 1: Exactly! And that’s the crux of the matter, isn't it? We’re essentially playing god with the building blocks of life. If we start correcting genetic predispositions to diseases, where do we draw the line? It seems like a slippery slope toward designer babies and a new kind of eugenics.
Speaker 2: Well, to be fair, one could argue that it’s our moral obligation to alleviate human suffering if the technology exists. If you could prevent a child from inheriting a debilitating, terminal illness, wouldn't it be unethical *not* to intervene?
Speaker 1: That’s a valid point, certainly. But that assumes we can perfectly predict the long-term consequences. We might be solving one problem only to inadvertently trigger a cascade of unforeseen biological issues in future generations.
Speaker 2: You’re talking about the unintended consequences, which is a legitimate concern. However, scientific oversight and international regulations are supposed to mitigate those risks.
Speaker 1: Are they, though? Regulations often lag significantly behind the pace of innovation. By the time a law is passed, the technology has already moved three steps ahead. It feels like we’re running a race where the rules are being written mid-sprint.
Speaker 2: I suppose you have a point there. The regulatory framework is often reactive rather than proactive. It’s a massive challenge for global governance.
Speaker 1: It really is. It’s not just about the science; it’s about the societal impact. If these technologies are only available to the wealthy, we’re looking at a profound widening of social inequality.
Speaker 2: Precisely. We’re talking about a biological divide to match the economic one. It’s a chilling thought, really.
SEGMENT 2 — MONOLOGUE
Narrator: Good morning, listeners. Today, we are delving into a subject that sits at the very heart of modern intellectual discourse: the ethics of scientific research. For decades, the scientific community has operated under the guiding principle of advancing human knowledge and improving the quality of life. However, as our capabilities expand from the microscopic to the cosmological, the ethical frameworks we rely on are being pushed to their absolute limits.
Narrator: Traditionally, ethical research was governed by principles such as autonomy, beneficence, and justice. We understood that subjects must give informed consent and that the risks must be weighed against the potential benefits. Yet, in the contemporary landscape, these concepts are becoming increasingly nuanced. Take, for instance, the advent of artificial intelligence in medical diagnostics. While the efficiency is undeniable, we face profound questions regarding accountability. If an algorithm misdiagnoses a patient, where does the liability lie? Is it with the developer, the clinician, or the machine itself?
Narrator: Furthermore, we must consider the concept of 'dual-use' research. This refers to scientific breakthroughs that, while intended for beneficial purposes, could be repurposed for harmful ends. A discovery in virology aimed at creating vaccines could, in theory, be manipulated to develop biological weapons. This creates a moral paradox: how do we foster an environment of open, transparent research while simultaneously guarding against catastrophic misuse?
Narrator: There is also the matter of the 'precautionary principle.' This principle suggests that if an action or policy has a suspected risk of causing harm to the public or the environment, in the absence of scientific consensus, the burden of proof falls on those proposing the action. In many scientific fields, this leads to a tension between cautious deliberation and the drive for innovation. Some argue that excessive caution stifles progress, while others maintain that once a biological or technological change is released into the wild, it is often irreversible.
Narrator: Ultimately, the ethics of science is not a static field of study. It is a dynamic, evolving conversation that requires constant scrutiny. As we stand on the precipice of unprecedented discoveries, it is imperative that we do not merely focus on the 'how' of science, but remain deeply invested in the 'why.' We must ensure that our pursuit of knowledge remains tethered to our humanity.
SEGMENT 3 — PANEL DISCUSSION
Speaker 1: Thank you all for joining us. To kick things off, I’d like to pose a question to our panel: can scientific research ever be truly neutral, or is it inherently biased by the values of the society that funds it?
Speaker 2: If I may jump in first, I’d argue that complete neutrality is a myth. Science is conducted by humans, and humans are products of their culture, politics, and economic realities. Even the choice of what to research—what questions we deem worthy of funding—is a value judgment.
Speaker 3: I tend to agree with Speaker 2, though I’d add a nuance. While the *direction* of research might be biased, the *methodology* aims for objectivity. We use the scientific method to mitigate personal bias. However, I concede that the socio-economic context certainly shapes the research agenda.
Speaker 1: But doesn't that bias lead to a neglect of certain areas? For instance, much of our pharmaceutical research is driven by profit margins, which means rare diseases in developing nations are often sidelined.
Speaker 2: That is precisely the problem. When profit becomes the primary driver of scientific inquiry, ethics often take a backseat to commercial viability. We see this in the way clinical trials are sometimes conducted in regions with laxer regulations to save costs. It’s a deeply troubling trend.
Speaker 3: While that is a valid criticism, we shouldn't paint all industry-funded research with the same brush. Many life-saving innovations would be impossible without private investment. The challenge is to create a balance where commercial interests don't override ethical imperatives.
Speaker 1: But how do we achieve that balance in a globalized market? If one country has strict ethical guidelines and another doesn't, won't the research simply migrate to the less regulated environment?
Speaker 2: That's the 'race to the bottom' scenario, and it's a very real threat. It's why we need international cooperation and standardized ethical protocols. We can't have a fragmented approach where ethics are treated as a local variable.
Speaker 3: I'm slightly more skeptical about the feasibility of global standardization. Different cultures have vastly different views on what constitutes 'ethical.' What is acceptable in one society might be considered an outrage in another.
Speaker 1: Which brings us back to our initial dilemma. If there is no universal ethical standard, how do we govern the global scientific community? It seems we are facing a profound crisis of consensus.
Speaker 2: It is a crisis, certainly. But perhaps the goal shouldn't be a single, rigid set of rules, but rather a shared commitment to fundamental human rights that transcends borders.
Speaker 3: A reasonable hope, but an incredibly difficult one to implement in practice.
